Difference between revisions of "Team:SDU-Denmark"
| Line 30: | Line 30: | ||
<img src="https://static.igem.org/mediawiki/2015/d/da/SDU2015_frontpageImage.jpg" width="820px" /> | <img src="https://static.igem.org/mediawiki/2015/d/da/SDU2015_frontpageImage.jpg" width="820px" /> | ||
<a class="cover boxcaption" style="top: 465px" href="https://2015.igem.org/Team:SDU-Denmark/Tour10"> | <a class="cover boxcaption" style="top: 465px" href="https://2015.igem.org/Team:SDU-Denmark/Tour10"> | ||
| − | <h2 class="onBlack"> | + | <h2 class="onBlack">PAST (Peptide Aptamer Screening using Two-Hybrid System) is the future </h2> |
<p class="onBlackIntro"> | <p class="onBlackIntro"> | ||
| − | + | This is a project focusing on finding an alternative to the traditional antibody production. | |
</p> | </p> | ||
<p class="onBlack"> | <p class="onBlack"> | ||
| − | |||
Currently, all marketed antibodies are made in vitro, by exploiting mammalian cell's immune system and its ability to produce antibodies against a certain antigen. Increasing demands implies the necessity of quicker methods to drive down the costs of production, both because of economical issues and the expense of animal lives. These are exactly the issues that we have been trying to accommodate. Sounds interesting, right? Take a tour through our wiki either by the menu function or the tourmenu. Enjoy! | Currently, all marketed antibodies are made in vitro, by exploiting mammalian cell's immune system and its ability to produce antibodies against a certain antigen. Increasing demands implies the necessity of quicker methods to drive down the costs of production, both because of economical issues and the expense of animal lives. These are exactly the issues that we have been trying to accommodate. Sounds interesting, right? Take a tour through our wiki either by the menu function or the tourmenu. Enjoy! | ||
</p> | </p> | ||
Revision as of 02:27, 19 September 2015
